PPA
PGNX
Parametric Portfolio Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-131,590
| Closed | -$500K | – | 4055 |
|
2020
Q1 | $500K | Sell |
131,590
-13,640
| -9% | -$51.8K | ﹤0.01% | 3163 |
|
2019
Q4 | $739K | Sell |
145,230
-26,898
| -16% | -$137K | ﹤0.01% | 3213 |
|
2019
Q3 | $870K | Sell |
172,128
-109,719
| -39% | -$555K | ﹤0.01% | 3097 |
|
2019
Q2 | $1.74M | Buy |
281,847
+79,392
| +39% | +$490K | ﹤0.01% | 2760 |
|
2019
Q1 | $939K | Sell |
202,455
-58,383
| -22% | -$271K | ﹤0.01% | 3061 |
|
2018
Q4 | $1.1M | Buy |
260,838
+122,343
| +88% | +$514K | ﹤0.01% | 2928 |
|
2018
Q3 | $868K | Sell |
138,495
-108,604
| -44% | -$681K | ﹤0.01% | 3175 |
|
2018
Q2 | $1.99M | Buy |
247,099
+68,893
| +39% | +$554K | ﹤0.01% | 2699 |
|
2018
Q1 | $1.33M | Sell |
178,206
-15,825
| -8% | -$118K | ﹤0.01% | 2863 |
|
2017
Q4 | $1.15M | Buy |
194,031
+74,465
| +62% | +$443K | ﹤0.01% | 2944 |
|
2017
Q3 | $880K | Buy |
119,566
+6,513
| +6% | +$47.9K | ﹤0.01% | 3107 |
|
2017
Q2 | $768K | Buy |
113,053
+11,804
| +12% | +$80.2K | ﹤0.01% | 3126 |
|
2017
Q1 | $956K | Buy |
101,249
+25,413
| +34% | +$240K | ﹤0.01% | 2879 |
|
2016
Q4 | $655K | Buy |
+75,836
| New | +$655K | ﹤0.01% | 3051 |
|
2015
Q4 | – | Sell |
-22,745
| Closed | -$130K | – | 4004 |
|
2015
Q3 | $130K | Sell |
22,745
-37,530
| -62% | -$215K | ﹤0.01% | 3163 |
|
2015
Q2 | $450K | Buy |
60,275
+18,009
| +43% | +$134K | ﹤0.01% | 3347 |
|
2015
Q1 | $253K | Sell |
42,266
-50,463
| -54% | -$302K | ﹤0.01% | 3649 |
|
2014
Q4 | $701K | Sell |
92,729
-50,152
| -35% | -$379K | ﹤0.01% | 3055 |
|
2014
Q3 | $742K | Buy |
142,881
+34,004
| +31% | +$177K | ﹤0.01% | 2916 |
|
2014
Q2 | $469K | Buy |
108,877
+949
| +0.9% | +$4.09K | ﹤0.01% | 3243 |
|
2014
Q1 | $441K | Buy |
107,928
+50,709
| +89% | +$207K | ﹤0.01% | 3246 |
|
2013
Q4 | $305K | Buy |
+57,219
| New | +$305K | ﹤0.01% | 3416 |
|